Screening, prophylaxis, and challenges: Tumor necrosis factor inhibitors and latent tuberculosis infection nexus in rheumatology
Authors:
- 7 December 2023
- journal article
- editorial
- Published by Wiley in International Journal of Rheumatic Diseases
- Vol. 27 (1)
Abstract
No abstract availableFunding Information
- Science, Technology and Innovation Commission of Shenzhen Municipality (JCYJ2021032413181)
This publication has 22 references indexed in Scilit:
- Treatment of latent tuberculosis infection in patients receiving biologic agentsJournal of Infection and Chemotherapy, 2021
- Immunogenicity of TNF-InhibitorsFrontiers in Immunology, 2020
- Infection risk in patients undergoing treatment for inflammatory arthritis: non-biologics versus biologicsExpert Review of Clinical Immunology, 2020
- British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adultsGut, 2019
- Tumor Necrosis Factor-Alpha Antagonist Interferes With the Formation of Granulomatous Multinucleated Giant Cells: New Insights Into Mycobacterium tuberculosis InfectionFrontiers in Immunology, 2019
- Risk of tuberculosis reactivation associated with traditional disease modifying anti-rheumatic drugs and non-anti-tumor necrosis factor biologics in patients with rheumatic disorders and suggestion for clinical practiceExpert Opinion on Drug Safety, 2019
- High rates of tuberculin skin test positivity due to methotrexate therapy: False positive results?Seminars in Arthritis and Rheumatism, 2018
- Preventive therapy for tuberculosis in rheumatological patients undergoing therapy with biological drugsExpert Review of Anti-infective Therapy, 2018
- Tuberculosis screening prior to anti‐tumor necrosis factor therapy among patients with immune‐mediated inflammatory diseases in Japan: a longitudinal study using a large‐scale health insurance claims databaseInternational Journal of Rheumatic Diseases, 2017
- Detection of latent tuberculosis in immunosuppressed patients with autoimmune diseases: performance of a Mycobacterium tuberculosis antigen-specific interferon γ assayAnnals of the Rheumatic Diseases, 2008